B cells for in vivo delivery of therapeutic agents and dosages thereof
作者： Herbig Eric J , Scholz Matthew Rein , Mcivor R Scott , Olson Erik , De Laat Rian
DOI:
关键词:
摘要: The present invention relates to methods for administering autologous and/or allogeneic B cells genetically modified produce a therapeutic agent, such as protein. Specifically disclosed are single, maximally effective dose of and multiple doses cells. compositions herein useful the long-term, in vivo delivery agent.
lens.org 参考文章(5)
Eric J. Herbig, Matthew Rein Scholz, Vectors and methods for transducing b cells ,(2011)
Eric J. Herbig, Matthew Rein Scholz, Mei Xu, Methods for in vitro memory b cell differentiation and transduction with vsv-g pseudotyped viral vectors ,(2014)
Michael Goldberg, Vera Greiner, Composition and methods of genome editing of B-cells ,(2016)
Eric J. Herbig, Matthew Rein Scholz, Rian De Laat, Mei Xu, B cells for in vivo delivery of therapeutic agents ,(2015)
Lalitha R. Belur, Karen Kozarsky, R. Scott Mcivor, Adeno-associated virus for therapeutic delivery to central nervous system ,(2016)